These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26914843)

  • 1. Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report.
    Ruiz-Delgado GJ; León Peña AA; Gómez-de-León A; Ruiz-Argüelles GJ
    Hematology; 2016 Sep; 21(8):470-3. PubMed ID: 26914843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.
    Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O; Geneviève F; Schmidt A; Hunault-Berger M
    Eur J Haematol; 2018 Oct; 101(4):570-574. PubMed ID: 30007088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
    Hertenstein B; Hambach L; Bacigalupo A; Schmitz N; McCann S; Slavin S; Gratwohl A; Ferrant A; Elmaagacli A; Schwertfeger R; Locasciulli A; Zander A; Bornhäuser M; Niederwieser D; Ruutu T;
    Haematologica; 2005 Jul; 90(7):969-75. PubMed ID: 15996934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor cell leukemia: a review.
    Wiseman DH
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):771-89. PubMed ID: 20951819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor cell leukemia: insight into cancer stem cells and the stem cell niche.
    Flynn CM; Kaufman DS
    Blood; 2007 Apr; 109(7):2688-92. PubMed ID: 17132724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report.
    Hoffmann M; Banz Y; Halter J; Schoumans J; Tchinda J; Bacher U; Pabst T
    Curr Oncol; 2024 Apr; 31(4):2067-2075. PubMed ID: 38668056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of the therapeutic effects between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation in treatment of leukemia].
    Yang K; Liu QF; Fan ZP; Sun J; Xu D; Wei YQ; Zhang Y; Meng FY
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):135-9. PubMed ID: 17445441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia.
    Rodríguez-Macías G; Martínez-Laperche C; Gayoso J; Noriega V; Serrano D; Balsalobre P; Muñoz-Martínez C; Díez-Martín JL; Buño I
    Hum Pathol; 2013 Aug; 44(8):1696-9. PubMed ID: 23465275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Donor cell-derived hematological malignancies after allogeneic hematopoietic stem cell transplantation].
    Kato M
    Rinsho Ketsueki; 2017; 58(7):813-817. PubMed ID: 28781279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of patients with mixed-lineage-leukemia-rearranged acute leukemia: Results from a prospective, multi-center study.
    Wang Y; Liu QF; Qin YZ; Liu DH; Xu LP; Jiang B; Jiang Q; Dai M; Yu SJ; Jiang XM; Liu YR; Huang XJ
    Am J Hematol; 2014 Feb; 89(2):130-6. PubMed ID: 24122923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes.
    Mo XD; Kong J; Zhao T; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2023-8. PubMed ID: 25196855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: case report.
    Lorenzoni PJ; Scola RH; Carsten AL; Trentin AP; Teive HA; Pasquini R; Werneck LC
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):700-4. PubMed ID: 17876419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?
    Koç H; Gürman G; Arslan O; Ozcan M; Dilek I; Akan H; Ilhan O; Konuk N; Beksaç M; Uysal A
    J Chemother; 1997 Oct; 9(5):371-6. PubMed ID: 9373793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.
    Alimoghaddam K; Ghavamzadeh A; Jahani M; Jalali A; Jorjani H; Iravani M; Hamidieh AA; Mousavi A; Bahar B; Behfar M; Derakhshandeh R; Rostami S
    Arch Iran Med; 2011 Sep; 14(5):332-4. PubMed ID: 21888457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allogeneic stem cell transplantation for 75 cases of acute myeloid leukemia in complete remission: outcome and prognostic analysis].
    Song AX; Yang DL; Wei JL; Yan ZS; Wang M; Jiang EL; Huang Y; Liu QG; Ma QL; Zhai WH; Zhang RL; Feng SZ; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):161-6. PubMed ID: 20137139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.